Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine is more effective than betamethasone for treating alopecia areata, despite mild side effects.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Triamcinolone acetonide is more effective than cryotherapy for hair regrowth in alopecia areata but has different side effects.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

CTP-543 is generally safe for treating alopecia areata.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib treatment is used for teenagers with alopecia areata.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Topical tofacitinib is effective and safe for treating alopecia areata.

Lowering the dose of cyclosporin caused hair loss that didn't improve even when the dose was increased again.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.